David J. Snyderman serves as Executive at MedTech Acquisition Corp, where they oversee executive responsibilities. Since joining the company, David J. Snyderman has executed 202 insider transactions totaling $673.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 12, 2023 involved transacting 42,567 shares valued at $446.5K.
David J. Snyderman currently holds 855,866 shares of MedTech Acquisition Corp (MTAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David J. Snyderman has been a net seller of MTAC stock. They have purchased $0 and sold $673.2M worth of shares.
David J. Snyderman's most recent insider trade was on Jun 12, 2023, when they sold 42,567 shares at $10.49 per share.
Get notified when new Form 4 filings are submitted
| $10.49 |
| Discretionary |